Tukysa 50 mg
Tukysa 50 mg is a medicine authorised by Swissmedic under authorisation number 67798. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 07 May 2020 and the authorisation is valid without a time limit. ATC code L01EH03 places the medicine in the group Antineoplastic agents.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tukysa 50 mg, Filmtabletten | A | 07 May 2020 |
| 2 | Tukysa 150 mg, Filmtabletten | A | 07 May 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 88 | Tablette(n) | L01EH03 | 07.16.1. | A |
| 2 | 84 | Tablette(n) | L01EH03 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Tukysa 50 mg authorised in Switzerland?
Yes. Tukysa 50 mg is authorised by Swissmedic under authorisation number 67798, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tukysa 50 mg have?
Tukysa 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tukysa 50 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.